| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 76.67 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : 0.46 |
EPS(TTM) : 20.69 |
|
Book Value(₹) : 203.39 |
Market Cap(₹Cr) : 21,607.40 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 637.58 | 567.90 | 395.71 | 390.00 | 428.75 | 449.17 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 637.58 | 567.90 | 395.71 | 390.00 | 428.75 | 449.17 |
| Other Operating Income | 12.92 | 10.74 | 9.06 | 9.73 | 7.81 | 7.52 |
| Other Income | 23.59 | 22.68 | 16.75 | 7.79 | 5.81 | 5.16 |
| Total Income | 674.09 | 601.32 | 421.52 | 407.52 | 442.37 | 461.85 |
| Total Expenditure | 353.62 | 362.32 | 283.80 | 300.16 | 293.93 | 333.31 |
| PBIDT | 320.47 | 239.00 | 137.72 | 107.36 | 148.44 | 128.54 |
| Interest | 46.50 | 45.14 | 53.16 | 54.65 | 56.26 | 56.17 |
| PBDT | 273.97 | 193.86 | 84.56 | 52.71 | 92.18 | 72.37 |
| Depreciation | 39.30 | 37.60 | 43.38 | 46.68 | 46.16 | 45.55 |
| Tax | 40.91 | 27.17 | 8.51 | 0.00 | 8.78 | 4.69 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 44.19 | 29.10 | 2.20 | 4.25 | 9.14 | 5.09 |
| Reported Profit After Tax | 149.57 | 99.99 | 30.47 | 1.78 | 28.10 | 17.04 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 149.57 | 99.99 | 30.47 | 1.78 | 28.10 | 17.04 |
| EPS (Unit Curr.) | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 | 1.25 |
| EPS (Adj) (Unit Curr.) | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 | 1.25 |
| Calculated EPS (Unit Curr.) | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 | 1.25 |
| Calculated EPS (Adj) (Unit Curr.) | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 | 1.25 |
| Calculated EPS (Ann.) (Unit Curr.) | 43.93 | 29.37 | 8.95 | 0.52 | 8.26 | 5.01 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 43.93 | 29.37 | 8.95 | 0.52 | 8.26 | 5.01 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 735.00 | 0.00 | 0.00 |
| Equity | 13.62 | 13.62 | 13.62 | 13.61 | 13.61 | 13.61 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 50.26 | 42.08 | 34.80 | 27.53 | 34.62 | 28.62 |
| PBDTM(%) | 42.97 | 34.14 | 21.37 | 13.52 | 21.50 | 16.11 |
| PATM(%) | 23.46 | 17.61 | 7.70 | 0.46 | 6.55 | 3.79 |